Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3858)
All Articles published online
|
Oct 1, 2004 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ren ZG, Lin ZY, Xia JL, Ye SL, Ma ZC, Ye QH, Qin LX, Wu ZQ, Fan J, Tang ZY. Postoperative adjuvant arterial chemoembolization improves survival of hepatocellular carcinoma patients with risk factors for residual tumor: A retrospective control study. World J Gastroenterol 2004; 10(19): 2791-2794 [PMID: 15334671 DOI: 10.3748/wjg.v10.i19.2791] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i19/2791.htm |
| Number | Citing Articles |
| 1 |
Zhendong Gao, Gang Du, Yuguang Pang, Zhihao Fu, Chongzhong Liu, Yi Liu, Binghai Zhou, Du Kong, Binyao Shi, Zhengcheng Jiang, Bin Jin. Adjuvant transarterial chemoembolization after radical resection contributed to the outcomes of hepatocellular carcinoma patients with high-risk factors. Medicine 2017; 96(33): e7426 doi: 10.1097/MD.0000000000007426
|
| 2 |
Jing-Hang Jiang, Zhe Guo, Hao-Feng Lu, Xiao-Bo Wang, Hao-Jie Yang, Fu-Quan Yang, Si-Yang Bao, Jian-Hong Zhong, Le-Qun Li, Ri-Rong Yang, Bang-De Xiang. Adjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: Propensity score analysis. World Journal of Gastroenterology 2015; 21(15): 4627-4634 doi: 10.3748/wjg.v21.i15.4627
|
| 3 |
Jia-hong Wang, Xiao-shan Li, Hong-sheng Tang, Run-ya Fang, Jing-jing Song, Yan-lin Feng, Tian-pei Guan, Qiang Ruan, Jin Wang, Shu-Zhong Cui. Vessels that encapsulate tumor clusters (VETC) pattern predicts the efficacy of adjuvant TACE in hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology 2023; 149(8): 4163 doi: 10.1007/s00432-022-04323-4
|
| 4 |
Jian‐Hong Zhong, Le‐Qun Li. Postoperative adjuvant transarterial chemoembolization for participants with hepatocellular carcinoma: A meta‐analysis. Hepatology Research 2010; 40(10): 943 doi: 10.1111/j.1872-034X.2010.00710.x
|
| 5 |
Fumitoshi Hirokawa, Koji Komeda, Kohei Taniguchi, Mitsuhiro Asakuma, Tetsunosuke Shimizu, Yoshihiro Inoue, Shuji Kagota, Atsushi Tomioka, Kazuhiro Yamamoto, Kazuhisa Uchiyama. Is Postoperative Adjuvant Transcatheter Arterial Infusion Therapy Effective for Patients with Hepatocellular Carcinoma who Underwent Hepatectomy? A Prospective Randomized Controlled Trial. Annals of Surgical Oncology 2020; 27(11): 4143 doi: 10.1245/s10434-020-08699-w
|
| 6 |
Yun-Fan Sun, Yang Xu, Xin-Rong Yang, Wei Guo, Xin Zhang, Shuang-Jian Qiu, Ruo-Yu Shi, Bo Hu, Jian Zhou, Jia Fan. Circulating stem cell–like epithelial cell adhesion molecule–positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection. Hepatology 2013; 57(4): 1458 doi: 10.1002/hep.26151
|
| 7 |
Shaoqi Zong, Guokai Huang, Bo Pan, Shasha Zhao, Changquan Ling, Binbin Cheng. A Hypoxia-Related miRNA-mRNA Signature for Predicting the Response and Prognosis of Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2024; : 525 doi: 10.2147/JHC.S454698
|
| 8 |
Dong Hui, Li Qiang, Wang Jian, Zhang Ti, Kong Da-Lu. A randomized, controlled trial of postoperative adjuvant cytokine-induced killer cells immunotherapy after radical resection of hepatocellular carcinoma. Digestive and Liver Disease 2009; 41(1): 36 doi: 10.1016/j.dld.2008.04.007
|
| 9 |
Jia-Zhou Ye, Yan-Yan Wang, Tao Bai, Jie Chen, Bang-De Xiang, Fei-Xiang Wu, Le-Qun Li. Surgical resection for hepatocellular carcinoma with portal vein tumor thrombus in the Asia-Pacific region beyond the Barcelona Clinic Liver Cancer treatment algorithms: a review and update. Oncotarget 2017; 8(54): 93258 doi: 10.18632/oncotarget.18735
|
| 10 |
Xingshun Qi, Lei Liu, Diya Wang, Hongyu Li, Chunping Su, Xiaozhong Guo. Hepatic resection alone versus in combination with pre- and post-operative transarterial chemoembolization for the treatment of hepatocellular carcinoma: A systematic review and meta-analysis. Oncotarget 2015; 6(34): 36838 doi: 10.18632/oncotarget.5426
|
| 11 |
Wei-Ren Liu, Meng-Xin Tian, Chen-Yang Tao, Zheng Tang, Yu-Fu Zhou, Shu-Shu Song, Xi-Fei Jiang, Han Wang, Pei-Yun Zhou, Wei-Feng Qu, Yuan Fang, Zhen-Bin Ding, Jian Zhou, Jia Fan, Ying-Hong Shi. Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis. BMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-07138-z
|
| 12 |
Seth J Karp, Yonson Ku, Scott Johnson, Khalid Khwaja, Michael Curry, Douglas Hanto. Surgical and non-surgical approaches to hepatocellular cancer. Current Opinion in Organ Transplantation 2006; 11(3): 226 doi: 10.1097/01.mot.0000227837.06582.94
|
| 13 |
James E Pingpank. Therapy for Unresectable Hepatocellular Carcinoma. The Cancer Journal 2004; 10(5): 291 doi: 10.1097/00130404-200409000-00005
|
| 14 |
Qian Zhou, Xiao-Qing Zhou, Tao Zhang. Reactivation of hepatitis B virus after transarterial chemoembolization and therapeutic effect of antiviral drugs. World Chinese Journal of Digestology 2019; 27(10): 651 doi: 10.11569/wcjd.v27.i10.651
|
| 15 |
Xiao-shan Li, Jia-hong Wang, Xian-zi Yang, Lei Ma, Yan-xia Shi, Ye Song, Peng Jiang, Sha Gao, Ye Dong, Jin-rong Lin, Chuan Jin. Beneficial effects of Cripto-1 for transarterial chemoembolization in hepatocellular carcinoma. Aging 2019; 11(10): 2998 doi: 10.18632/aging.101951
|
| 16 |
Jin-Shu Zeng, Jian-Xing Zeng, Yao Huang, Jing-Feng Liu, Jin-Hua Zeng. The effect of adjuvant transarterial chemoembolization for hepatocellular carcinoma after liver resection based on risk stratification. Hepatobiliary & Pancreatic Diseases International 2023; 22(5): 482 doi: 10.1016/j.hbpd.2022.07.007
|
| 17 |
Xiaohong Chen, Boheng Zhang, Xin Yin, Zhenggang Ren, Shuangjian Qiu, Jian Zhou. Lipiodolized transarterial chemoembolization in hepatocellular carcinoma patients after curative resection. Journal of Cancer Research and Clinical Oncology 2013; 139(5): 773 doi: 10.1007/s00432-012-1343-7
|
| 18 |
C.J. YOON, J.W. CHUNG. Surgery of the Liver, Biliary Tract and Pancreas. 2007; : 1218 doi: 10.1016/B978-1-4160-3256-4.50089-2
|
| 19 |
Chu-Yu Jing, Yi-Peng Fu, Su-Su Zheng, Yong Yi, Hu-Jia Shen, Jin-Long Huang, Xin Xu, Jia-Jia Lin, Jian Zhou, Jia Fan, Zheng-Gang Ren, Shuang-Jian Qiu, Bo-Heng Zhang. Prognostic nomogram for patients with hepatocellular carcinoma underwent adjuvant transarterial chemoembolization following curative resection. Medicine 2017; 96(11): e6140 doi: 10.1097/MD.0000000000006140
|
| 20 |
Xiaoyun Zhang, Chuan Li, Tianfu Wen, Lunan Yan, Bo Li, Jiayin Yang, Wentao Wang, Mingqing Xu, Wusheng Lu, Li Jiang. Appropriate treatment strategies for intrahepatic recurrence after curative resection of hepatocellular carcinoma initially within the Milan criteria. European Journal of Gastroenterology & Hepatology 2015; 27(8): 933 doi: 10.1097/MEG.0000000000000383
|
| 21 |
Xin-Rong Yang, Yang Xu, Bin Yu, Jian Zhou, Jia-Chu Li, Shuang-Jian Qiu, Ying-Hong Shi, Xiao-Ying Wang, Zhi Dai, Guo-Ming Shi, Bin Wu, Li-Ming Wu, Guo-Huan Yang, Bo-Heng Zhang, Wen-Xin Qin, Jia Fan. CD24 Is a Novel Predictor for Poor Prognosis of Hepatocellular Carcinoma after Surgery. Clinical Cancer Research 2009; 15(17): 5518 doi: 10.1158/1078-0432.CCR-09-0151
|
| 22 |
Laura Marelli, Rosa Stigliano, Christos Triantos, Marco Senzolo, Evangelos Cholongitas, Neil Davies, Dominic Yu, Tim Meyer, David W. Patch, A.K. Burroughs. Treatment outcomes for hepatocellular carcinoma using chemoembolization in combination with other therapies. Cancer Treatment Reviews 2006; 32(8): 594 doi: 10.1016/j.ctrv.2006.08.002
|
| 23 |
Zheng Wang, Zhenggang Ren, Yi Chen, Jie Hu, Guohuan Yang, Lei Yu, Xinrong Yang, Ao Huang, Xin Zhang, Shaolai Zhou, Huichuan Sun, Yanhong Wang, Ningling Ge, Xiaoyu Xu, Zhaoyou Tang, Wanyee Lau, Jia Fan, Jiping Wang, Jian Zhou. Adjuvant Transarterial Chemoembolization for HBV-Related Hepatocellular Carcinoma After Resection: A Randomized Controlled Study. Clinical Cancer Research 2018; 24(9): 2074 doi: 10.1158/1078-0432.CCR-17-2899
|
| 24 |
Jianyong Lei, Jinjing Zhong, Jingcheng Hao, Zhengni Liu, Peng Zhang, Lixue Wu, Lunan Yan, Jinqiang Zhu, Yong Zeng, Bo Li, Tianfu Wen, Wentao Wang. Hepatocellular carcinoma cases with high levels of c-Raf-1 expression may benefit from postoperative adjuvant sorafenib after hepatic resection even with high risk of recurrence. Oncotarget 2106; 7(27): 42598 doi: 10.18632/oncotarget.3799
|
| 25 |
Xuejun Kuang, Jiazhou Ye, Zhibo Xie, Tao Bai, Jie Chen, Wenfeng Gong, Lunan Qi, Jianhong Zhong, Liang Ma, Ningfu Peng, Bangde Xiang, Feixiang Wu, Guobin Wu, Haihong Ye, Changmiao Wang, Lunqun Li. Adjuvant transarterial chemoembolization to improve the prognosis of hepatocellular carcinoma following curative resection. Oncology Letters 2018; doi: 10.3892/ol.2018.9244
|
| 26 |
Li-feng Huang, Xianglei Xing, Dong Wu, Yong Xia, Jun Li, Kui Wang, Zhen-lin Yan, Xu-ying Wan, Le-hua Shi, Tian Yang, Wan Yee Lau, Meng-chao Wu, Feng Shen. A novel scoring system predicts adjuvant chemolipiodolization benefit for hepatocellular carcinoma patients after hepatectomy. Oncotarget 2016; 7(18): 25493 doi: 10.18632/oncotarget.8333
|
| 27 |
Fang Wang, Qingqing Chen, Yuanyuan Zhang, Yinan Chen, Yajing Zhu, Wei Zhou, Xiao Liang, Yunjun Yang, Hongjie Hu. CT-Based Radiomics for the Recurrence Prediction of Hepatocellular Carcinoma After Surgical Resection. Journal of Hepatocellular Carcinoma 2022; : 453 doi: 10.2147/JHC.S362772
|
| 28 |
Wen Chen, Tao Ma, Jian Zhang, Xiaozhen Zhang, Wei Chen, Yinan Shen, Xueli Bai, Tingbo Liang. A systematic review and meta-analysis of adjuvant transarterial chemoembolization after curative resection for patients with hepatocellular carcinoma. HPB 2020; 22(6): 795 doi: 10.1016/j.hpb.2019.12.013
|
| 29 |
H. E. Blum, L. Lan, H. C Spangenberg. Future Perspectives in Gastroenterology. 2008; : 241 doi: 10.1007/978-1-4020-8833-9_21
|
| 30 |
Liming Wang, Weihu Wang, Xuesong Yao, Weiqi Rong, Fan Wu, Bo Chen, Mei Liu, Shengtao Lin, Yunhe Liu, Jianxiong Wu. Postoperative adjuvant radiotherapy is associated with improved survival in hepatocellular carcinoma with microvascular invasion. Oncotarget 2017; 8(45): 79971 doi: 10.18632/oncotarget.20402
|
| 31 |
WEN-FENG GONG, JIAN-HONG ZHONG, BANG-DE XIANG, LE-QUN LI. Feasibility of combining adjuvant transarterial chemoembolization with nucleos(t)ide analog therapy for patients with HBV-associated hepatocellular carcinoma after hepatectomy. Molecular and Clinical Oncology 2016; 5(1): 3 doi: 10.3892/mco.2016.871
|
| 32 |
Jingxian Gu, Xing Zhang, Ruixia Cui, Jia Zhang, Zhixin Wang, Yifan Jia, Runchen Miao, Yanyan Dong, Xiaohua Ma, Haining Fan, Haijiu Wang, Li Ren, Yiming Li, Wenquan Niu, Jingyao Zhang, Kai Qu, Chang Liu. Prognostic predictors for patients with hepatocellular carcinoma receiving adjuvant transcatheter arterial chemoembolization. European Journal of Gastroenterology & Hepatology 2019; 31(7): 836 doi: 10.1097/MEG.0000000000001346
|
| 33 |
Feng Zhang, Ke-Shu Hu, Shen-Xin Lu, Miao Li, Rong-Xin Chen, Zheng-Gang Ren, Ying-Hong Shi, Xin Yin. Prognostic significance of preoperative systemic immune-inflammation index in combined hepatocellular-cholangiocarcinoma. Cancer Biomarkers 2021; 31(3): 211 doi: 10.3233/CBM-200643
|
| 34 |
S G Lee, S Hwang, J P Jung, Y J Lee, K H Kim, C S Ahn. Outcome of patients with huge hepatocellular carcinoma after primary resection and treatment of recurrent lesions. British Journal of Surgery 2007; 94(3): 320 doi: 10.1002/bjs.5622
|
| 35 |
Jian Huang, Fu-Chen Liu, Li Li, Sheng-Xian Yuan, Yuan Yang, Bei-Ge Jiang, Hui Liu, Ze-Ya Pan. Prognostic Nomogram for Hepatitis B Virus–related Hepatocellular Carcinoma With Adjuvant Transarterial Chemoembolization After Radical Resection. American Journal of Clinical Oncology 2020; 43(1): 20 doi: 10.1097/COC.0000000000000619
|
| 36 |
Peng‐Xiang Wang, Yun‐Fan Sun, Kai‐Qian Zhou, Jian‐Wen Cheng, Bo Hu, Wei Guo, Yue Yin, Jun‐Feng Huang, Jian Zhou, Jia Fan, Tan To Cheung, Xu‐Dong Qu, Xin‐Rong Yang. Circulating tumor cells are an indicator for the administration of adjuvant transarterial chemoembolization in hepatocellular carcinoma: A single‐center, retrospective, propensity‐matched study. Clinical and Translational Medicine 2020; 10(3) doi: 10.1002/ctm2.137
|
| 37 |
Jian Zhou, Hui-Chuan Sun, Zheng Wang, Wen-Ming Cong, Jian-Hua Wang, Meng-Su Zeng, Jia-Mei Yang, Ping Bie, Lian-Xin Liu, Tian-Fu Wen, Guo-Hong Han, Mao-Qiang Wang, Rui-Bao Liu, Li-Gong Lu, Zheng-Gang Ren, Min-Shan Chen, Zhao-Chong Zeng, Ping Liang, Chang-Hong Liang, Min Chen, Fu-Hua Yan, Wen-Ping Wang, Yuan Ji, Wen-Wu Cheng, Chao-Liu Dai, Wei-Dong Jia, Ya-Ming Li, Ye-Xiong Li, Jun Liang, Tian-Shu Liu, Guo-Yue Lv, Yi-Lei Mao, Wei-Xin Ren, Hong-Cheng Shi, Wen-Tao Wang, Xiao-Ying Wang, Bao-Cai Xing, Jian-Ming Xu, Jian-Yong Yang, Ye-Fa Yang, Sheng-Long Ye, Zheng-Yu Yin, Bo-Heng Zhang, Shui-Jun Zhang, Wei-Ping Zhou, Ji-Ye Zhu, Rong Liu, Ying-Hong Shi, Yong-Sheng Xiao, Zhi Dai, Gao-Jun Teng, Jian-Qiang Cai, Wei-Lin Wang, Jia-Hong Dong, Qiang Li, Feng Shen, Shu-Kui Qin, Jia Fan. Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition). Liver Cancer 2018; 7(3): 235 doi: 10.1159/000488035
|
| 38 |
Yin Zhu, Pei-Jing Cui, Jing Yao, Zheng-Yun Zhang, Jun Yang. Efficacy of Transarterial Chemoembolisation with or without Antiviral Therapy for Patients with Hepatocellular Carcinoma after Radical Hepatectomy. Gastroenterology Research and Practice 2018; 2018: 1 doi: 10.1155/2018/6414759
|
| 39 |
Ya Ruth Huo, Michael Vinchill Chan, Christine Chan. Resection Plus Post-operative Adjuvant Transcatheter Arterial Chemoembolization (TACE) Compared with Resection Alone for Hepatocellular Carcinoma: A Systematic Review and Meta-analysis. CardioVascular and Interventional Radiology 2020; 43(4): 572 doi: 10.1007/s00270-019-02392-6
|
| 40 |
Yangyang Wang, Hongbin Ge, Manyi Hu, Changrong Pan, Mao Ye, Dipesh Kumar Yadav, Rujia Zheng, Jiajun Wu, Ke Sun, Meng Wang, Yu Tian, Jinyan Huang, Weiyun Yao, Jingsong Li, Qi Zhang, Tingbo Liang. Histological tumor micronecrosis in resected specimens after R0 hepatectomy for hepatocellular carcinomas is a factor in determining adjuvant TACE: A retrospective propensity score-matched study. International Journal of Surgery 2022; 105: 106852 doi: 10.1016/j.ijsu.2022.106852
|
| 41 |
Long-Hai Feng, Yu-Yao Zhu, Jia-Min Zhou, Miao Wang, Wei-Qi Xu, Ti Zhang, An-Rong Mao, Wen-Ming Cong, Hui Dong, Lu Wang. Adjuvant TACE may not improve recurrence-free or overall survival in HCC patients with low risk of recurrence after hepatectomy. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1104492
|
| 42 |
Peng‐Yuan Zhuang, Ju‐Bo Zhang, Xiao‐Dong Zhu, Wei Zhang, Wei‐Zhong Wu, Yun‐Shan Tan, Jun Hou, Zhao‐You Tang, Lun‐Xiu Qin, Hui‐Chuan Sun. Two pathologic types of hepatocellular carcinoma with lymph node metastasis with distinct prognosis on the basis of CK19 expression in tumor. Cancer 2008; 112(12): 2740 doi: 10.1002/cncr.23488
|
| 43 |
Wing‐Hong Li, Moon‐Tong Cheung. Recurrence and survival for hepatocellular carcinoma after curative resection: Tertiary centre experience. Surgical Practice 2008; 12(2): 45 doi: 10.1111/j.1744-1633.2008.00400.x
|
| 44 |
Qiang YAN, Jun NI, Guo-lei ZHANG, Xing YAO, Wen-bin YUAN, Lin ZHOU, Shu-sen ZHENG. Efficacy of postoperative antiviral combined transcatheter arterial chemoembolization therapy in prevention of hepatitis B-related hepatocellular carcinoma recurrence. Chinese Medical Journal 2013; 126(5): 855 doi: 10.3760/cma.j.issn.0366-6999.20121871
|
| 45 |
Jian-wen Huang, Bing Liu, Bao-shan Hu, Yong Li, Xu He, Wei Zhao, You-bing Zheng, Li-gong Lu. RETRACTED ARTICLE: Clinical value of circulating tumor cells for the prognosis of postoperative transarterial chemoembolization therapy. Medical Oncology 2014; 31(9) doi: 10.1007/s12032-014-0175-5
|
| 46 |
Hae-Na Shin, Shin Hwang, Ki-Hun Kim, Chul-Soo Ahn, Deok-Bog Moon, Tae-Yong Ha, Gi-Won Song, Young-Joo Lee, Sung-Gyu Lee. Role of the 1-month protocol transarterial chemoinfusion in detecting intrahepatic metastasis after resection of large hepatocellular carcinoma greater than 10 cm. Korean Journal of Hepato-Biliary-Pancreatic Surgery 2013; 17(4): 157 doi: 10.14701/kjhbps.2013.17.4.157
|
| 47 |
Zhenwei Peng, Xiaoxue Wu, Jiaping Li, Hui Pang, Yaojun Zhang, Manxia Lin, Zaiguo Wang, Han Xiao, Bin Li, Minshan Chen, Shiting Feng, Ming Kuang, Shuling Chen. The role of neoadjuvant conventional transarterial chemoembolization with radiofrequency ablation in the treatment of recurrent hepatocellular carcinoma after initial hepatectomy with microvascular invasion. International Journal of Hyperthermia 2022; 39(1): 688 doi: 10.1080/02656736.2022.2051613
|
| 48 |
Ghassan K. Abou-Alfa, Leonard B. Saltz. Blumgart's Surgery of the Liver, Pancreas and Biliary Tract. 2012; : 1444 doi: 10.1016/B978-1-4377-1454-8.00088-6
|
| 49 |
Hans Christian Spangenberg, Robert Thimme, Hubert E Blum. Advances in prevention and diagnosis of hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology 2008; 2(3): 425 doi: 10.1586/17474124.2.3.425
|
| 50 |
Jian Zhao, Yu Xie. Progress in research of hepatocellular carcinoma with tumor thrombus. World Chinese Journal of Digestology 2019; 27(20): 1239 doi: 10.11569/wcjd.v27.i20.1239
|
| 51 |
Yan-Yan Wang, Li-Jun Wang, Da Xu, Ming Liu, Hong-Wei Wang, Kun Wang, Xu Zhu, Bao-Cai Xing. Postoperative adjuvant transcatheter arterial chemoembolization should be considered selectively in patients who have hepatocellular carcinoma with microvascular invasion. HPB 2019; 21(4): 425 doi: 10.1016/j.hpb.2018.08.001
|
| 52 |
Toru Ishikawa, Kazuo Higuchi, Tomoyuki Kubota, Keiichi Seki, Terasu Honma, Toshiaki Yoshida, Tomoteru Kamimura. Prevention of intrahepatic distant recurrence by transcatheter arterial infusion chemotherapy with platinum agents for stage I/II hepatocellular carcinoma. Cancer 2011; 117(17): 4018 doi: 10.1002/cncr.25989
|
| 53 |
James J. Harding, Louise C. Connell, Imane El Dika, Ghassan K. Abou-Alfa. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set. 2017; : 1502 doi: 10.1016/B978-0-323-34062-5.00101-1
|
| 54 |
Mingheng Liao, Zexin Zhu, Haichuan Wang, Jiwei Huang. Adjuvant transarterial chemoembolization for patients after curative resection of hepatocellular carcinoma: a meta-analysis. Scandinavian Journal of Gastroenterology 2017; 52(6-7): 624 doi: 10.1080/00365521.2017.1292365
|
| 55 |
Jian Zhang, Tian-Yi Jiang, Bei-Ge Jiang, Chun Yang, Ye-Xiong Tan, Ning Yang, Yu-Fei Pan, Zhi-Wen Ding, Guang-Zhen Yang, Meng-Chao Wu, Li-Wei Dong, Hong-Yang Wang. RMP predicts survival and adjuvant TACE response in hepatocellular carcinoma. Oncotarget 2015; 6(5): 3432 doi: 10.18632/oncotarget.3092
|
| 56 |
Chong Zhong, Rong-ping Guo, Jin-qing Li, Ming Shi, Wei Wei, Min-shan Chen, Ya-qi Zhang. A randomized controlled trial of hepatectomy with adjuvant transcatheter arterial chemoembolization versus hepatectomy alone for Stage III A hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology 2009; 135(10): 1437 doi: 10.1007/s00432-009-0588-2
|
| 57 |
Yan-Jun Xiang, Ju-Xian Sun, Jia-Yi Wu, Kang Wang, Jin-Kai Feng, Yong-Gang Wei, Jian-Yin Zhou, Zhi-Bo Zhang, Yu-Qing Zhang, Ying-Yi Qin, Mao-Lin Yan, Shu-Qun Cheng. Recurrence hazard rate in patients with hepatocellular carcinoma and bile duct tumor thrombus: a multicenter observational study. HPB 2022; 24(10): 1703 doi: 10.1016/j.hpb.2022.04.007
|
| 58 |
Zhan-Qi Wei, Yue-Wei Zhang. Transcatheter arterial chemoembolization followed by surgical resection for hepatocellular carcinoma: a focus on its controversies and screening of patients most likely to benefit. Chinese Medical Journal 2021; 134(19): 2275 doi: 10.1097/CM9.0000000000001767
|
| 59 |
Tao Bai, Zhi-hong Tang, Xiao-bo Wang, Jie Chen, Jia-zhou Ye, Shao-long Lu, Meng Wei, Fei-xiang Wu, Le-qun Li. Radiotherapy is superior to transarterial chemoembolization as adjuvant therapy after narrow-margin hepatectomy in patients with hepatocellular carcinoma: A single-center prospective randomized study. Langenbeck's Archives of Surgery 2024; 409(1) doi: 10.1007/s00423-024-03249-4
|
| 60 |
Lei Liang, Chao Li, Yong-Kang Diao, Hang-Dong Jia, Hao Xing, Timothy M. Pawlik, Wan Yee Lau, Feng Shen, Dong-Sheng Huang, Cheng-Wu Zhang, Tian Yang. Survival benefits from adjuvant transcatheter arterial chemoembolization in patients undergoing liver resection for hepatocellular carcinoma: a systematic review and meta-analysis. Therapeutic Advances in Gastroenterology 2020; 13 doi: 10.1177/1756284820977693
|
| 61 |
Hui-Chuan Sun, Lu Xie, Xin-Rong Yang, Wei Li, Jian Yu, Xiao-Dong Zhu, Yong Xia, Ti Zhang, Yang Xu, Bo Hu, Li-Ping Du, Ling-Yao Zeng, Jian Ouyang, Wei Zhang, Tian-Qiang Song, Qiang Li, Ying-Hong Shi, Jian Zhou, Shuang-Jian Qiu, Qian Liu, Yi-Xue Li, Zhao-You Tang, Yu Shyr, Feng Shen, Jia Fan. Shanghai Score. Chinese Medical Journal 2017; 130(22): 2650 doi: 10.4103/0366-6999.218019
|
| 62 |
Surgery of the Liver, Biliary Tract and Pancreas. 2007; : 1298 doi: 10.1016/B978-1-4160-3256-4.50095-8
|
| 63 |
F. Li, Z. Guo, Y. Zhang, H. Wang, X. Zhang, T. Si, H. Yu, L. Qi. Postoperative adjuvant arterial chemoembolization improves the survival of hepatitis B virus-related hepatocellular carcinoma: a retrospective control study. Irish Journal of Medical Science (1971 -) 2015; 184(4): 753 doi: 10.1007/s11845-014-1164-6
|
| 64 |
Jia-hong Wang, Xiao-ping Zhong, Yong-fa Zhang, Xiao-liang Wu, Shao-hua Li, Pei-en Jian, Yi-hong Ling, Ming Shi, Min-shan Chen, Wei Wei, Rong-ping Guo. Cezanne predicts progression and adjuvant TACE response in hepatocellular carcinoma. Cell Death & Disease 2017; 8(9): e3043 doi: 10.1038/cddis.2017.428
|
| 65 |
|
| 66 |
Xin Yin, Lan Zhang, Yan-Hong Wang, Bo-Heng Zhang, Yu-Hong Gan, Ning-Lin Ge, Yi Chen, Li-Xin Li, Zheng-Gang Ren. Transcatheter arterial chemoembolization combined with radiofrequency ablation delays tumor progression and prolongs overall survival in patients with intermediate (BCLC B) hepatocellular carcinoma. BMC Cancer 2014; 14(1) doi: 10.1186/1471-2407-14-849
|
| 67 |
Yoji Kishi, Akio Saiura, Junji Yamamoto, Rintaro Koga, Makoto Seki, Ryo Morimura, Ryuji Yoshioka, Norihiro Kokudo, Toshiharu Yamaguchi. Repeat treatment for recurrent hepatocellular carcinoma: is it validated?. Langenbeck's Archives of Surgery 2011; 396(7): 1093 doi: 10.1007/s00423-011-0837-0
|
| 68 |
Xin-Qin Kang, Wei-Jin Zang, Li-Jun Bao, Dong-Ling Li，Tu-Sheng Song, Xiao-Li Xu, Xiao-Jiang Yu. Fibroblast growth factor-4 and hepatocyte growth factor induce differentiation of human umbilical cord blood-derived mesenchymal stem cells into hepatocytes. World Journal of Gastroenterology 2005; 11(47): 7461-7465 doi: 10.3748/wjg.v11.i47.7461
|